AdaptHealth (AHCO) EV to EBITDA (2019 - 2026)

AdaptHealth has reported EV to EBITDA for 8 years, with the latest figure at 55.39 in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 787.1% year-over-year to 55.39 in Q2 2026; TTM through Jun 2026 was 5.42, a 165.34% increase from a year earlier, with the FY2025 full-year figure at 2.76, up 42.32% from the prior year.
• EV to EBITDA was 55.39 for Q2 2026 at AdaptHealth, down from 14.74 in the prior quarter.
• The five-year high for EV to EBITDA was 65.07 in Q4 2025, with the low at 55.39 in Q2 2026.
• Average EV to EBITDA over 5 years is 9.9, with a median of 10.87 recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: EV to EBITDA soared 908.46% in 2025, then tumbled 787.1% in 2026.
• Over 5 years, EV to EBITDA stood at 21.37 in 2022, then plunged by 132.07% to 6.85 in 2023, then jumped by 194.13% to 6.45 in 2024, then jumped by 908.46% to 65.07 in 2025, then slumped by 185.12% to 55.39 in 2026.
• The last three EV to EBITDA figures came in at 55.39 (Q2 2026), 14.74 (Q1 2026), and 65.07 (Q4 2025), per Business Quant data.